Understanding the Development, Standardization, and Validation Process of Alternative In Vitro Test Methods for Regulatory Approval from a Researcher Perspective.
3Rs
alternative test methods
regulatory approval
standardization
validation
Journal
Small (Weinheim an der Bergstrasse, Germany)
ISSN: 1613-6829
Titre abrégé: Small
Pays: Germany
ID NLM: 101235338
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
revised:
05
12
2020
received:
26
09
2020
pubmed:
23
1
2021
medline:
15
7
2021
entrez:
22
1
2021
Statut:
ppublish
Résumé
Due to economic, practical, ethical, and scientific reasons, researchers, among others, are pushing for alternative in vitro test methods to replace or reduce existing animal experiments. In order for these tests to be more broadly used by the industrial sector and regulatory bodies, orchestrated efforts are required to show the robustness and reliability of in vitro methods, which can accelerate the use for early screening testing. Another way of increasing the use of alternatives is to coordinate validation studies, that is, multi-laboratory trials, and to gain regulatory approval and instatement as test guidelines or standard method. However, awareness of the exact standardization, validation, and approval process has been a major obstacle for many researchers. Herein, the process has been broken down into three main phases: i) test method development; ii) intra- and inter-laboratory validation; and iii) regulatory acceptance. This general process applies to all alternative methods seeking validation and approval, although the intricacies of different toxicological endpoints and/or chemical sectors may lead to additional work, particularly in the validation stage. The authors' aim is to provide insight in the development process of alternative methods with a focus on in vitro cell culture methods over validation to regulatory acceptance.
Identifiants
pubmed: 33480475
doi: 10.1002/smll.202006027
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2006027Informations de copyright
© 2021 The Authors. Small published by Wiley-VCH GmbH.
Références
E. Walum, J. Hedander, P. Garberg, Toxicol. Appl. Pharmacol. 2005, 207, 393.
A. Bal-Price, H. T. Hogberg, K. M. Crofton, M. Daneshian, R. E. FitzGerald, E. Fritsche, T. Heinonen, S. Hougaard Bennekou, S. Klima, A. H. Piersma, M. Sachana, T. J. Shafer, A. Terron, F. Monnet-Tschudi, B. Viviani, T. Waldmann, R. H. S. Westerink, M. F. Wilks, H. Witters, M. G. Zurich, M. Leist, Altex 2018, 35, 306.
W. M. S. Russell, R. L. Burch, The Principles of Humane Experimental Technique, Methuen, London, UK 1959.
J. Draize, G. Woodard, H. Calvery, J. Pharmacol. Exp. Ther. 1944, 82, 377.
M. York, W. Steiling, J. Appl. Toxicol. 1998, 18, 233.
D. Basketter, D. Jirova, H. Kandarova, Interdiscip. Toxicol. 2012, 5, 98.
M. Lee, J. H. Hwang, K. M. Lim, Toxicol. Res. 2017, 33, 191.
Organisation for Economic Co-operation and Development, In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method, OECD Guidelines for the Testing of Chemicals, Section 4 Test No. 439, OECD Publishing, Paris, France 2020.
Organisation for Economic Co-operation and Development, in Vitro Skin Irritation: Reconstructed Human Epidermis Test Method, OECD Guidelines for the Testing of Chemicals, Section 4 Test No. 439, OECD Publishing, Paris, France 2015.
M. Leist, T. Hartung, Arch. Toxicol. 2013, 87, 563.
H. R. Ferdowsian, N. Beck, PLoS One 2011, 6, e24059.
I. A. Freires, J. C. Sardi, R. D. de Castro, P. L. Rosalen, Pharm. Res. 2017, 34, 681.
H. Raunio, Front. Pharmacol. 2011, 2, 33.
N. Alepee, A. Bahinski, M. Daneshian, W. B. De, E. Fritsche, A. Goldberg, J. Hansmann, T. Hartung, J. Haycock, H. Hogberg, L. Hoelting, J. M. Kelm, S. Kadereit, E. McVey, R. Landsiedel, M. Leist, M. Lubberstedt, F. Noor, C. Pellevoisin, D. Petersohn, U. Pfannenbecker, K. Reisinger, T. Ramirez, B. Rothen-Rutishauser, M. Schafer-Korting, K. Zeilinger, M. G. Zurich, Altex 2014, 31, 441.
R. F. Luder, M. Buettner, A. Bleich, Altex 2019, 36, 141.
S. Gordon, M. Daneshian, J. Bouwstra, F. Caloni, S. Constant, D. E. Davies, G. Dandekar, C. A. Guzman, E. Fabian, E. Haltner, T. Hartung, N. Hasiwa, P. Hayden, H. Kandarova, S. Khare, H. F. Krug, C. Kneuer, M. Leist, G. Lian, U. Marx, M. Metzger, K. Ott, P. Prieto, M. S. Roberts, E. L. Roggen, T. Tralau, C. van den Braak, H. Walles, C. M. Lehr, Altex 2015, 32, 327.
K. Jaroch, A. Jaroch, B. Bojko, J. Pharm. Biomed. Anal. 2018, 147, 297.
J. Zavala, A. N. Freedman, J. T. Szilagyi, I. Jaspers, J. F. Wambaugh, M. Higuchi, J. E. Rager, Int. J. Environ. Res. Public Health 2020, 17, 2124.
http://www.oecd.org/chemicalsafety/risk-assessment/iata-integrated-approaches-to-testing-and-assessment.htm (accessed: November 2020).
A. Kinsner-Ovaskainen, G. Maxwell, J. Kreysa, J. Barroso, E. Adriaens, N. Alepee, N. Berg, S. Bremer, S. Coecke, J. Z. Comenges, R. Corvi, S. Casati, N. G. Dal, M. Marrec-Fairley, C. Griesinger, M. Halder, E. Heisler, D. Hirmann, A. Kleensang, A. Kopp-Schneider, S. Lapenna, S. Munn, P. Prieto, L. Schechtman, T. Schultz, J. M. Vidal, A. Worth, V. Zuang, ATLA, Altern. Lab. Anim. 2012, 40, 175.
C. Rovida, N. Alepee, A. M. Api, D. A. Basketter, F. Y. Bois, F. Caloni, E. Corsini, M. Daneshian, C. Eskes, J. Ezendam, H. Fuchs, P. Hayden, C. Hegele-Hartung, S. Hoffmann, B. Hubesch, M. N. Jacobs, J. Jaworska, A. Kleensang, N. Kleinstreuer, J. Lalko, R. Landsiedel, F. Lebreux, T. Luechtefeld, M. Locatelli, A. Mehling, A. Natsch, J. W. Pitchford, D. Prater, P. Prieto, A. Schepky, et al., Altex 2015, 32, 25.
Organisation for Economic Co-operation and Development, Revised Guidance Document for Developing and Assessing Adverse Outcome Pathways (AOPs), 2nd ed., ENV/JM/MONO(2013)6 Series on Testing and Assessment No. 184., OECD Publishing, Paris 2013.
S. Halappanavar, S. van den Brule, P. Nymark, L. Gate, C. Seidel, S. Valentino, V. Zhernovkov, P. Hogh Danielsen, A. De Vizcaya, H. Wolff, T. Stoger, A. Boyadziev, S. S. Poulsen, J. B. Sorli, U. Vogel, Part. Fibre Toxicol. 2020, 17, 16.
H. Barosova, A. G. Maione, D. Septiadi, M. Sharma, L. Haeni, S. Balog, O. O'Connell, G. R. Jackson, D. Brown, A. J. Clippinger, P. Hayden, A. Petri-Fink, V. Stone, B. Rothen-Rutishauser, ACS Nano 2020, 14, 3941.
https://www.epa.gov/sites/production/files/2019-09/documents/image2019-09-09-231249.pdf (accessed: November 2020).
https://ec.europa.eu/environment/pdf/chemicals/2020/10/Strategy.pdf (accessed: November 2020).
European Union, Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the Protection of Animals Used for Scientific Purposes, in Official Journal of the European Union 2010.
https://ec.europa.eu/health/sites/health/files/endocrine_disruptors/docs/cosmetic_1223_2009_regulation_en.pdf (accessed: November 2020).
https://echa.europa.eu/animal-testing-under-reach (accessed: November 2020).
https://ec.europa.eu/growth/sectors/chemicals/epaa_en (accessed: November 2020).
https://www.ecetoc.org/about-ecetoc/overview/ (accessed: November 2020).
https://hesiglobal.org/ (accessed: November 2020).
J. E. Doe, A. R. Boobis, A. Blacker, V. Dellarco, N. G. Doerrer, C. Franklin, J. I. Goodman, J. M. Kronenberg, R. Lewis, E. E. McConnell, T. Mercier, A. Moretto, C. Nolan, S. Padilla, W. Phang, R. Solecki, L. Tilbury, B. van Ravenzwaay, D. C. Wolf, Crit. Rev. Toxicol. 2006, 36, 37.
S. Fox, S. Farr-Jones, L. Sopchak, A. Boggs, H. W. Nicely, R. Khoury, M. Biros, J. Biomol. Screen. 2006, 11, 864.
https://www.oecd.org/env/ehs/testing/Validation-report_USENS.pdf (accessed: November 2020).
T. Hartung, E. van Vliet, J. Jaworska, L. Bonilla, N. Skinner, R. Thomas, Altex 2012, 29, 119.
W. Lilienblum, W. Dekant, H. Foth, T. Gebel, J. G. Hengstler, R. Kahl, P. J. Kramer, H. Schweinfurth, K. M. Wollin, Arch. Toxicol. 2008, 82, 211.
Organisation for Economic Co-operation and Development, Guidance document on the validation of (quantitative)structure-activity relationships [(Q)SAR] models, in OECD Series on Testing and Assessment, OECD Publishing, Paris, France 2007.
T. Hartung, Altex 2007, 24, 67.
https://eur-lex.europa.eu/eli/dir/2010/63/oj (accessed: November 2020).
I. A. S. Olsson, S. P. D. Silva, D. Townend, P. Sandoe, ILAR J. 2016, 57, 347.
H. Kandarova, S. Letasiova, Interdiscip.Toxicol. 2011, 4, 107.
https://www.oecd.org/about/ (accessed: November 2020).
https://www.oecd-ilibrary.org/ (accessed: November 2020).
https://www.oecd.org/env/ehs/testing/national-coordinators-test-guidelines-programme.htm (accessed: November 2020).
https://www.oecd.org/env/ehs/mutualacceptanceofdatamad.htm (accessed: November 2020).
Organisation for Economic Co-operation and Development, Guidance document on good in vitro method practices (GIVIMP), in OECD Series on Testing and Assessment No. 286, OECD Publishing, Paris 2018.
S. Coecke, M. Balls, G. Bowe, J. Davis, G. Gstraunthaler, T. Hartung, R. Hay, O. W. Merten, A. Price, L. Schechtman, G. Stacey, W. Stokes, ATLA, Altern. Lab. Anim. 2005, 33, 261.
M. Hofmann, C. Eskes, L. Aicher, Validierung und Implementierung von Ersatzmethoden bei Industriechemikalien: Aktivit,ten der Schweiz in einem internationalen Umfeld, Bundesamt fr Gesundheit 2014.
https://www.iso.org/members.html (accessed: November 2020).
https://www.iso.org/developing-standards.html (accessed: November 2020).
https://www.iso.org/publication/PUB100438.html (accessed: November 2020).
https://www.edqm.eu/en (accessed: November 2020).
https://www.edqm.eu/sites/default/files/technical_guide_for_the_elaboration_of_monographs_7th_edition_2015.pdf (accessed: November 2020).
J. M. Wiggins, J. A. Albanese, Monograph Development: Why and When to Participate in BioPharm International, Vol. 2020, 2020.
M. R. Nepal, T. C. Jeong, Biomol. Ther. 2020, 28, 302.
K. Taylor, C. Gericke, L. R. Alvarez, Altex 2019, 36, 81.
https://www.ich.org/ (accessed: November 2020).
K. B. Bayne, D. A. C. Bayvel, V. Williams, Laboratory Animal Welfare: International Issues, in Laboratory Animal Welfare (Eds: K. Bayne, P.V. Turner), Elsevier, Amsterdam 2014.
S. Beken, P. Kasper, J. W. van der Laan, Adv. Exp. Med. Biol. 2016, 856, 33.
C. Lourenco, N. Orphanos, C. Parker, Pharm. Policy Law 2016, 18, 79.
https://vichsec.org/en/library/vich-statements.html (accessed: November 2020).
Organisation for Economic Co-operation and Development, Guidance document on the validation and international acceptance of new or updated test methods for hazard assessment, in OECD Environment, Health and Safety Publications Series on Testing and Assessment No. 34 OECD Publishing, Paris 2005.
C. Griesinger, B. Desprez, S. Coecke, W. Casey, V. Zuang, Adv. Exp. Med. Biol. 2016, 856, 65.
https://ec.europa.eu/jrc/en/eurl/ecvam (accessed: November 2020).
https://ec.europa.eu/jrc/en/eurl/ecvam/alternative-methods-toxicity-testing/eu-netval (accessed: November 2020).
https://ntp.niehs.nih.gov/pubhealth/evalatm/resources-for-test-method-developers/index.html (accessed: November 2020).
A. A. Bottini, P. Amcoff, T. Hartung, Altex 2007, 24, 255.
W. S. Stokes, L. M. Schechtman, R. N. Hill, ATLA, Altern. Lab. Anim. 2002, 30, 23.
http://alttox.org/resource-center/testing-supplies-cells-tissue-software/#EQ.
M. Nakamura, T. Haarmann-Stemmann, J. Krutmann, A. Morita, Exp. Dermatol. 2018, 27, 495.
W. S. Stokes, L. M. Schechtman, Validation and Regulatory Acceptance of New, Revised, and Alternative Toxicological Methods in Principles and Methods of Toxicology (Ed: A. W. Hayes), Taylor and Francis, Oxfordshire, UK 2007.
C. S. Pridgeon, C. Schlott, M. W. Wong, M. B. Heringa, T. Heckel, J. Leedale, L. Launay, V. Gryshkova, S. Przyborski, R. N. Bearon, E. L. Wilkinson, T. Ansari, J. Greenman, D. F. G. Hendriks, S. Gibbs, J. Sidaway, R. L. Sison-Young, P. Walker, M. J. Cross, B. K. Park, C. E. P. Goldring, Arch. Toxicol. 2018, 92, 557.
S. Bitz, Altex 2010, 27, 114.
M. Whelan, C. Eskes, Adv. Exp. Med. Biol. 2016, 856, 387.
National Research Council, Intentional Human Dosing Studies for EPA Regulatory Purposes: Scientific and Ethical Issues, The National Academies Press, Washington, DC 2004, p. 226.
https://www.oecd.org/env/ehs/mutualacceptanceofdatamad.htm (accessed: November 2020).
C. D. B. Griesinger, S. Coecke, W. Casey, V. Zuang, Validation of Alternative In Vitro Methods in the Development and Approval of Pharmaceuticals in Validation of Alternative Methods for Toxicity Testing (Eds: M. Whelan, C. Eskes), Springer International Publishing, Switzerland 2016.
W. Stokes, Validation and Regulatory Acceptance of Toxicological Testing Methods and Strategies in Principles and Methods of Toxicology, 6th ed. (Eds: A. W. Hayes, C. L. Kruger), CRC Press, Boca Raton, FL 2014.
T. Hartung, S. Bremer, S. Casati, S. Coecke, R. Corvi, S. Fortaner, L. Gribaldo, M. Halder, S. Hoffmann, A. J. Roi, P. Prieto, E. Sabbioni, L. Scott, A. Worth, V. Zuang, ATLA, Altern. Lab. Anim. 2004, 32, 467.
F. P. Gruber, T. Hartung, Altex 2004, 21, 3.
D. Pamies, A. Bal-Price, A. Simeonov, D. Tagle, D. Allen, D. Gerhold, D. Yin, F. Pistollato, T. Inutsuka, K. Sullivan, G. Stacey, H. Salem, M. Leist, M. Daneshian, M. C. Vemuri, R. McFarland, S. Coecke, S. C. Fitzpatrick, U. Lakshmipathy, A. Mack, W. B. Wang, D. Yamazaki, Y. Sekino, Y. Kanda, L. Smirnova, T. Hartung, Altex 2017, 34, 95.
D. Pamies, A. Bal-Price, C. Chesne, S. Coecke, A. Dinnyes, C. Eskes, R. Grillari, G. Gstraunthaler, T. Hartung, P. Jennings, M. Leist, U. Martin, R. Passier, J. C. Schwamborn, G. N. Stacey, H. Ellinger-Ziegelbauer, M. Daneshian, Altex 2018, 35, 353.
R. S. Judson, R. S. Thomas, N. Baker, A. Simha, X. M. Howey, C. Marable, N. C. Kleinstreuer, K. A. Houck, Altex 2019, 36, 261.
Organisation for Economic Co-operation and Development, Guidance Document for Describing Non-Guide-line in Vitro Test Methods, in OECD Series on Testing and Assessment No. 211, OECD Publishing, Paris 2017.
A. Krebs, T. Waldmann, M. F. Wilks, B. M. A. Van Vugt-Lussenburg, B. Van der Burg, A. Terron, T. Steger-Hartmann, J. Ruegg, C. Rovida, E. Pedersen, G. Pallocca, M. Luijten, S. B. Leite, S. Kustermann, H. Kamp, J. Hoeng, P. Hewitt, M. Herzler, J. G. Hengstler, T. Heinonen, T. Hartung, B. Hardy, F. Gantner, E. Fritsche, K. Fant, J. Ezendam, T. Exner, T. Dunkern, D. R. Dietrich, S. Coecke, et al., Altex 2019, 36, 682.
https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd-gd34.pdf (accessed: November 2020).
www.alttox.org (accessed: November 2020).
https://www.oecd-ilibrary.org/ (accessed: November 2020).
https://tsar.jrc.ec.europa.eu/ (accessed: November 2020)
R. Osborne, M. A. Perkins, Toxicol. In Vitro 1991, 5, 563.
H. Spielmann, S. Hoffmann, M. Liebsch, P. Botham, J. H. Fentem, C. Eskes, R. Roguet, J. Cotovio, T. Cole, A. Worth, J. Heylings, P. Jones, C. Robles, H. Kandarova, A. Gamer, M. Remmele, R. Curren, H. Raabe, A. Cockshott, I. Gerner, V. Zuang, ATLA, Altern. Lab. Anim. 2007, 35, 559.
www.mattek.com (accessed: November 2020).
www.loreal.com (accessed: November 2020).
D. De Wever, D. Petersohn, K. R. Mewes, Household Pers. Care Today 2013, 8, 18.
https://ecvam-dbalm.jrc.ec.europa.eu/ (accessed: November 2020).
M. Faria, M. Bjornmalm, K. J. Thurecht, S. J. Kent, R. G. Parton, M. Kavallaris, A. P. R. Johnston, J. J. Gooding, S. R. Corrie, B. J. Boyd, P. Thordarson, A. K. Whittaker, M. M. Stevens, C. A. Prestidge, C. J. H. Porter, W. J. Parak, T. P. Davis, E. J. Crampin, F. Caruso, Nat. Nanotechnol. 2018, 13, 777.
United Stated Environmental Protection Agency, Guidance for Preparing Standard Operating Procedures (SOPs) 2007.
Organisation for Economic Co-operation and Development, OECD Publishing, Paris 2016.
Organisation for Economic Co-operation and Development, The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins, OECD Series on Testing and Assessment No. 168, OECD Publishing, Paris 2014.
K. Rasmussen, H. Rauscher, P. Kearns, M. Gonzalez, J. Riego Sintes, Regul. Toxicol. Pharmacol. 2019, 104, 74.
S. Gottardo, M. Alessandrelli, V. Amenta, R. Atluri, G. Barberio, C. Bekker, P. Bergonzo, E. Bleeker, A. M. Booth, T. Borges, P. Buttol, D. Carlander, S. Castelli, S. Chevillard, S. Clavaguera, S. Dekkers, C. Delpivo, P. D. P. Fanghella, M. Dusinska, J. Einola, E. Ekokoski, C. Fito, H. Gouveia, R. Grall, K. Hoehener, P. Jantunen, G. Johanson, P. Laux, H. C. Lehmann, R. Leinonen, et al., Eur Scientific and Technical Research Reports, Publications Office of the European Union, Luxembourg 2017.
K. G. Steinhäuser, P. G. Sayre, NanoImpact 2017, 7, 66.
K. Taylor, Altex 2014, 31, 215.
F. Sewell, J. Doe, N. Gellatly, I. Ragan, N. Burden, Regul. Toxicol. Pharmacol. 2017, 89, 50.
Interagency Coordinating Committee on the Validation of Alternative Methods, A Strategic Roadmap for Establishing New Approaches to Evaluate the Safety of Chemicals and Medical Products in the United States, https://ntp.niehs.nih.gov/go/iccvam-rdmp (accessed: November 2020).